Details for 2011771664
Up to date per 03.04.2026
Actions
Details for 2011771664
Deleted
European Patent
06.03.2013 A
14.10.2020 B1
27.10.2010
US
407436 P
19.04.2010
US
325763 P
28.02.2011
US
447611 P
A61K 31/11 20060101AFI20130812BHEP
Owner
Retinagenix Therapeutics, Inc.421 Kipling Street Palo Alto, California 94301US
Representative
No representatives present
Inventor
STRONG, H., Andrew4459 Lions Avenue North Vancouver, British Colombia V7R 3S7CA
CADDEN, Suzanne2235 Alden Lane North Vancouver, British Columbia V7P 2J7CA
BOCH, Ronald Erwin5118 Redonda Drive North Vancouver, British Colombia V7R 3K2CA